Our Recommendations
- Beschluss der STIKO zur 19. Aktualisierung der COVID-19-Impfempfehlung und die dazugehörige wissenschaftliche Begründung (2022)
- Recommandations provisoires concernant l’utilisation du vaccin ChAdOx1-S [recombinant] contre la COVID-19 (vaccin anti-COVID-19 AZD1222 Vaxzevria™ d’AstraZeneca, COVISHIELD™ de SII) (2021)
- Statement on the Efficacy of the AstraZeneca COVID-19 Vaccine (ChAdOx1 nCoV-19) against the SARS-CoV-2 Variants (2021)
- Interim recommendations for use of the ChAdOx1-S [recombinant] vaccine against COVID-19 (AstraZeneca COVID-19 vaccine AZD1222 Vaxzevria™, SII COVISHIELD™) (2022)
- Déclaration sur l’efficacité du vaccin COVID-19 d’AstraZeneca (ChAdOx1 nCoV-19) contre les variants du SARS-CoV-2 (2021)
New Publications
- Recomendações provisórias para o uso da vacina ChAdOx1-S [recombinante] contra COVID-19 (vacina AstraZeneca COVID-19 AZD1222 Vaxzevria™, SII COVISHIELD™) - Última atualização em 30 de julho de 2021 (2021)
- Предварительные рекомендации по применению вакцины ChAdOx1-S [рекомбинантной] против COVID-19 (вакцина AstraZeneca COVID-19 AZD1222, Vaxzevria™, SII COVISHIELD™) (2021)
- Recommandations provisoires concernant l’utilisation du vaccin ChAdOx1-S [recombinant] contre la COVID-19 (vaccin anti-COVID-19 AZD1222 Vaxzevria™ d’AstraZeneca, COVISHIELD™ de SII) (2021)
- Documento de referência sobre a vacina AZD1222 contra COVID-19 desenvolvida pela Universidade de Oxford e pela AstraZeneca, 1 de março de 2021 (2021)
- Beschluss der STIKO zur 19. Aktualisierung der COVID-19-Impfempfehlung und die dazugehörige wissenschaftliche Begründung (2022)
Filter
26
Featured
Recommendations
6
Language
Document type
Fact sheets
14
Guidelines
6
Studies & Reports
4
Manuals
1
Situation Updates
1
Countries / Regions
West and Central Africa
3
East and Southern Africa
3
India
3
Germany
2
Brazil
2
South Sudan
2
Western and Central Europe
1
South Korea
1
Authors & Publishers
Publication Years
Category
Countries
12
On the 9 February 2021, Africa CDC convened a special session of the Africa Task Force for COVID-19 to review existing data and evidence and recommend
New England Journal of Medicine
April 9, 2021
DOI: 10.1056/NEJMoa2104840
7 April 2021
Based on current information, a causal relationship between the vaccine and the occurrence of blood clots with low platelets is considered plausible but is not confirmed.
Available in Englisch, French and Russian
